Drug Shortage Report for XYLOCAINE 2% WITH EPINEPHRINE 1:200000

Last updated on 2024-01-04 History
Report ID 183684
Drug Identification Number 02373130
Brand name XYLOCAINE 2% WITH EPINEPHRINE 1:200000
Common or Proper name lidocaine HCI 2% w/epin. 1:200M 10x20mL MD Vial
Company Name ASPEN PHARMACARE CANADA INC.
Market Status MARKETED
Active Ingredient(s) EPINEPHRINE LIDOCAINE HYDROCHLORIDE
Strength(s) 0.005MG 20MG
Dosage form(s) SOLUTION
Route of administration BLOCK/INFILTRATION BLOCK/INFILTRATION
Packaging size 10 vials
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-08-15
Actual start date 2023-08-04
Estimated end date 2024-01-01
Actual end date 2024-01-03
Shortage status Resolved
Updated date 2024-01-04
Company comments VR44551CA1 XYLOCAIN AD20MG:5MCG/ML MDV10X20ML CA AS
Health Canada comments
Tier 3 Status No
Contact Address UNIT 8, 1155 NORTH SERVICE ROAD WEST
OAKVILLE, ONTARIO
CANADA L6M 3E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2024-01-04 French Compare
v19 2024-01-04 English Compare
v18 2023-12-12 French Compare
v17 2023-12-12 English Compare
v16 2023-11-28 French Compare
v15 2023-11-28 English Compare
v14 2023-10-27 French Compare
v13 2023-10-27 English Compare
v12 2023-09-18 French Compare
v11 2023-09-18 English Compare
v10 2023-09-16 English Compare
v9 2023-07-11 French Compare
v8 2023-07-11 English Compare
v7 2023-07-06 French Compare
v6 2023-07-06 English Compare
v5 2023-07-02 English Compare
v4 2023-04-04 French Compare
v3 2023-04-04 English Compare
v2 2023-02-06 French Compare
v1 2023-02-06 English Compare

Showing 1 to 20 of 20